| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 10/20/2004 | CN1538956A Spiro compounds |
| 10/20/2004 | CN1538951A Omega-aminoalkylamides of R-2-aryl-propionic acids as inhibitors of chemotaxis of polymorphonucleate and mononucleate cells |
| 10/20/2004 | CN1538848A Novel Benzo-fused heterocycles |
| 10/20/2004 | CN1538838A Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 10/20/2004 | CN1537598A Traditional Chinese medicine Conghuang bushen granule for tonifying kidney, and its prepn. method |
| 10/20/2004 | CN1537588A Wenshen Qianlie granule for warming kidney and treating prostatic disorders, and its prepn. method |
| 10/20/2004 | CN1537576A Jinjia paishi granule for discharging calculus, and its prepn. method |
| 10/20/2004 | CN1537574A Granule for treating prostatic gland retention, and its prepn. method |
| 10/20/2004 | CN1537541A Applicaton of montmorillonite inpreparing medicine |
| 10/20/2004 | CN1171889C Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase |
| 10/20/2004 | CN1171601C Medicine for treating nephrosis and lung disease |
| 10/19/2004 | US6806370 NK-1 receptor active amine oxide prodrugs |
| 10/19/2004 | US6806312 Thermoplastic resin composition |
| 10/19/2004 | US6806278 Amino-tetralin derivatives as muscarinic receptor antagonists |
| 10/19/2004 | US6806262 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 10/19/2004 | US6805878 Transdermal administration of ACE inhibitors |
| 10/19/2004 | US6805864 Type I angiotensin II receptor specific monoclonal antibodies and hybridomas |
| 10/19/2004 | US6805863 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss |
| 10/19/2004 | CA2323096C Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 10/14/2004 | WO2004087172A1 T-type calcium channel blockers |
| 10/14/2004 | WO2004087165A1 Therapeutic agent for prostatic hypertrophy |
| 10/14/2004 | WO2004087125A1 Amino acid derivatives as inhibitors of mammalian sodium channels |
| 10/14/2004 | WO2004042402A3 Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) |
| 10/14/2004 | WO2004016769A3 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 10/14/2004 | US20040204599 an end-terminal group, which is isopropyl, sec.-butyl, or tert.-butyl group; a leading group; and a long-chain aliphatic, non-cyclic, saturated or unsaturated, hydrocarbon group that links end-terminal group and leading group; for cancer therapy, prevention, and immune boosting and inflammation functions |
| 10/14/2004 | US20040204582 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 10/14/2004 | US20040204500 Preventives/remedies for organ functional disorders and organ dysfunction |
| 10/14/2004 | US20040204482 provides a defined blood concentration profile having no rapid initial rise in blood plasma concentration of the good soluble active substance when administered; (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide; nervous system, gastrointestinal, heart disorders, Alzheimer's |
| 10/14/2004 | US20040204465 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 10/14/2004 | US20040204428 Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligandsof the adenosine a2a receptor and their use as medicaments |
| 10/14/2004 | US20040204422 N-[(Piperazinyl)hetaryl]arylsulfonamide compounds |
| 10/14/2004 | US20040204418 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease |
| 10/14/2004 | US20040204417 For therapy of cancer |
| 10/14/2004 | US20040204408 Piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 10/14/2004 | US20040204392 use of trilostane or a 3-enol C1-4 alkanoate ester thereof; treatment of Cushing's syndrome in humans and veterinary animals |
| 10/14/2004 | US20040204390 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| 10/14/2004 | US20040204369 Novel amide derivatives |
| 10/14/2004 | US20040204364 Peptides for activation and inhibition of deltaPKC |
| 10/14/2004 | US20040202679 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 10/13/2004 | EP1466925A1 Antibodies against fibroblast growth factor 23 |
| 10/13/2004 | EP1466902A1 Androgen receptor antagonists |
| 10/13/2004 | EP1466625A1 Preventives/remedies for urinary disturbance |
| 10/13/2004 | EP1466624A1 Drug for regenerating tissue and vessel and method therefor |
| 10/13/2004 | EP1466602A1 Organ fibrosis inhibitors |
| 10/13/2004 | EP1466596A1 Novel microsphere and method for production thereof |
| 10/13/2004 | EP1466017A2 Tissue rejection |
| 10/13/2004 | EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 10/13/2004 | EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 10/13/2004 | EP1465870A2 Substituted 4-phenyltetrahydroisoquinolinium salts, method for production and use thereof as a medicament and medicaments comprising the same |
| 10/13/2004 | EP1465863A1 Potassium channel modulators |
| 10/13/2004 | EP1465854A2 Chalcone derivatives and their use to treat diseases |
| 10/13/2004 | EP1465688A1 Bicarbonate-based solutions for dialysis therapies |
| 10/13/2004 | EP1465659A2 Use of a novel cell surface protease from group b streptococcus |
| 10/13/2004 | EP1465654A2 Plasmid mediated suplementation for treating chronically ill subjects |
| 10/13/2004 | EP1465645A1 A novel herbal chemical composition for the treatment of cancer |
| 10/13/2004 | EP1465638A2 Phosphate transport inhibitors |
| 10/13/2004 | EP1465626A2 Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses |
| 10/13/2004 | EP1465623A1 Urea derivatives |
| 10/13/2004 | EP1465619A1 Suppression of cartilage degradation via the estrogen receptor |
| 10/13/2004 | EP1465592A2 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 10/13/2004 | EP1430031A4 Kinetic resolution of a intermediate useful in the production of benazepril and analogues thereof |
| 10/13/2004 | EP1322309A4 High affinity small molecule c5a receptor modulators |
| 10/13/2004 | EP1280820B1 Anti-inflammatory compounds and uses thereof |
| 10/13/2004 | EP1211253B1 Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents |
| 10/13/2004 | EP1207866B1 Delayed-action form of administration containing tramadol saccharinate |
| 10/13/2004 | EP1202965B1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 10/13/2004 | EP1185529B1 Pyrazolobenzodiazepines as cdk2 inhibitors |
| 10/13/2004 | EP1150954B1 Anti-imflammatory indole derivatives |
| 10/13/2004 | EP1087786B1 Methods and materials for the treatment of prostatic carcinoma |
| 10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 10/13/2004 | CN1537103A Kinetic resolution of intermediater body for preparing benazepril and its analogues |
| 10/13/2004 | CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 10/13/2004 | CN1537093A Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 10/13/2004 | CN1537025A 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide |
| 10/13/2004 | CN1537019A Medical combination of aldosterone receptor antagonist and HMG CoA reductase inhibitor |
| 10/13/2004 | CN1537015A Stable liquid formulations of antibodies |
| 10/13/2004 | CN1537003A Pharmaceutical composition comprising tricyclic compound for prevention or treatment of skin diseases |
| 10/13/2004 | CN1537002A Novel theterocyclic analogs of diphenylethylene compounds |
| 10/13/2004 | CN1535682A Medicine for improved bladder excretion capacity |
| 10/13/2004 | CN1170941C Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 10/13/2004 | CN1170849C Connective tissue growth factor fragments and methods and uses thereof |
| 10/13/2004 | CN1170585C Remedies for nervous diseases |
| 10/13/2004 | CN1170536C Use of preparing medicine for preventing vomit using tetrahydrobenzo [cd] indole-6-formylamine compound |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803365 Imidazo[1,3,5]triazinones and the use thereof |
| 10/07/2004 | WO2004084924A1 Pharmaceutical composition for treatment of bph and preparation thereof |
| 10/07/2004 | WO2004084919A1 Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood |
| 10/07/2004 | WO2004065392A8 Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands |
| 10/07/2004 | WO2004062681A8 Herbal compositions for prostate conditions |
| 10/07/2004 | WO2004062666A3 Use of rho-kinase inhibitorrs for treatment of benign prostatic hyperplasia |
| 10/07/2004 | WO2004054514A3 C-6 modified indazolylpyrrolotriazines |
| 10/07/2004 | WO2004048386A3 THIENO[3,2-b]PYRIDINE-6-CARBONITRILES AND THIENO[2,3-b]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS |
| 10/07/2004 | WO2003076427A8 Quinazoline compounds useful in therapy |
| 10/07/2004 | WO2003053973A8 Pyrazolyl-substituted triazoloquinoxalines |
| 10/07/2004 | WO2003049679A3 Mitotic kinesin inhibitors |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198976 Method for synthesizing pyrazolobenzodiazepines |
| 10/07/2004 | US20040198824 enzyme inhibitor; anticancer agents; analgesics; vision defects |
| 10/07/2004 | US20040198796 Compounds and methods for treating urinary incontinence |
| 10/07/2004 | US20040198791 Fused imidazole derivative |